Relevant bibliographies by topics / Alpha-blockers

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Alpha-blockers'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Alpha-blockers.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Alpha-blockers"

1

Barbalias, George A. "Why Alpha-Blockers in Prostatitis?" European Urology Supplements 2, no. 2 (2003): 27–29. http://dx.doi.org/10.1016/s1569-9056(02)00197-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bos, Derek, and Anil Kapoor. "Update on medical expulsive therapy for distal ureteral stones: Beyond alpha-blockers." Canadian Urological Association Journal 8, no. 11-12 (2014): 442. http://dx.doi.org/10.5489/cuaj.2472.

Full text
Abstract:
Medical expulsive therapy (MET) has been described as an effective conservative treatment option in the initial management of small distal ureteral stones. Therapies that have been investigated include alpha-blockers, calcium channel blockers, corticosteroids, and most recently phosphodiesterase-5 inhibitors (PDE5) inhibitors. While alpha-blockers are currently the only recommended monotherapy, corticosteroids have received increased attention as a potential useful adjunct in the medical management of distal stones. PDE5 inhibitors are a novel treatment alternative, requiring further investiga
APA, Harvard, Vancouver, ISO, and other styles
3

Koski, Renee R., and William H. Zufall. "Efficacy and Safety of Alpha-Blockers for Kidney Stones in Adults." Journal of Pharmacy Technology 34, no. 2 (2017): 54–61. http://dx.doi.org/10.1177/8755122517750398.

Full text
Abstract:
Objective: To review the literature for α-blocker treatment of kidney stones. Data Sources: PubMed search performed November 15, 2017, using the following search terms: alpha-blocker, alfuzosin, silodosin, or tamsulosin AND kidney or ureteral stones. Additional studies found through references of primary and tertiary literature. Inclusion criteria included English language, randomized controlled trials (not included in meta-analyses), and meta-analyses evaluating US available alpha-blockers as medical expulsive therapy with or without lithotripsy in adults with renal or ureteral stones, and no
APA, Harvard, Vancouver, ISO, and other styles
4

Knyazev, O. V., A. V. Kagramanova, M. Yu Zvyaglova та ін. "Эффективность препарата устекинумаб у пациента с язвенным колитом после неудачи терапии блокаторами ФНО-альфа, блокатором янус-киназ и ингибитором альфа-4-бета-7-интегрина". Effective Pharmacotherapy 16, № 30 (2020): 24–31. http://dx.doi.org/10.33978/2307-3586-2020-16-30-24-31.

Full text
Abstract:
On specific examples the article demonstrates the clinical efficacy of ustekinumab in severe ulcerative colitis after failure of therapy with tumor necrosis factor alpha blockers, Janus kinase blockers, and alpha-4-beta-7-integrin inhibitors.
APA, Harvard, Vancouver, ISO, and other styles
5

Bapir, Rawa, Kamran Hassan Bhatti, Ahmed Eliwa, et al. "Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis." Archivio Italiano di Urologia e Andrologia 94, no. 2 (2022): 252–63. http://dx.doi.org/10.4081/aiua.2022.2.252.

Full text
Abstract:
Background: Alpha-adrenoreceptor antagonists or alpha-blockers are used in the treatment of hypertension, in the therapy of benign prostatic hyperplasia and in medical expulsive treatment of ureteral stones. These agents may affect the sexual function, with differences between drugs within the same class, depending on their selectivity for receptor subtypes. The aim of this review was to analyze the effects of alpha-blockers on sexual function. Materials and methods: We conducted a systematic review and meta-analysis by searching PubMed, EMBASE and other databases for randomized controlled tri
APA, Harvard, Vancouver, ISO, and other styles
6

Debruyne, Frans M. J. "Alpha blockers: are all created equal?" Urology 56, no. 5 (2000): 20–22. http://dx.doi.org/10.1016/s0090-4295(00)00744-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Das, Sambhunath, Pankaj Kumar, Usha Kiran, and Balram Airan. "Alpha blockers: A relook at phenoxybenzamine." Journal of the Practice of Cardiovascular Sciences 3, no. 1 (2017): 11. http://dx.doi.org/10.4103/jpcs.jpcs_42_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kirby, Roger. "LUTS, alpha-blockers and men's health." Trends in Urology & Men's Health 7, no. 6 (2016): 14–16. http://dx.doi.org/10.1002/tre.551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jounela, A. J., E. Kanniainen, and M. Lilja. "Interaction between clonidine and alpha blockers." Clinical Cardiology 8, no. 12 (1985): 641–42. http://dx.doi.org/10.1002/clc.4960081206.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sarhad Khan, Romana Bibi, Abdul Ullah, et al. "Lower Ureteric Stone Expulsion under the Effect of Alpha Blockers: A Clinical Trial over Alpha Blockers Efficacy." Journal of Saidu Medical College, Swat 12, no. 3 (2022): 138–42. http://dx.doi.org/10.52206/jsmc.2022.12.3.707.

Full text
Abstract:
Background: The ureters account for over 20% of urinary tract stones. The lifetime chance of having urinary calculi is between 5-12%, and men are more likely than women to develop them. There are a variety of minimally invasive interventional (ESWL and Ureteroscopy) and expectant options. However, the optimum therapy is mostly determined by the type and size of the stone, as well as the stone's location and the patient's demands. We do minimal invasive procedures like ureterostomy and ESWL to remove stone in ureter with some complications.
 Objective: To determine the efficacy of alpha bl
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Alpha-blockers"

1

Manio, Michael Magtoto. "In vivo exposure to lipopolysaccharide unmasks contractions to the alpha2-adrenergic agonist dexmedetomidine in the rat aorta." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/208015.

Full text
Abstract:
Dexmedetomidine is α2-adrenergic agent and commonly used in the intensive care setting. It is used primarily to sedate critically ill patients in various surgical, endoscopic and radiologic procedures. This medication gained superiority with other sedatives with a distinct advantage of less depression of the respiratory system. Although dexmedetomidine is often administered to septic patients, the vascular effect has not been fully studied in this clinical setting. In this thesis, rats were administered saline or bacterial lipopolysaccharide (LPS) 1, 10 and 20 mg/kg. Aortic rings were obtai
APA, Harvard, Vancouver, ISO, and other styles
2

Liu, Jie. "Intranasal dexmedetomidine for sedation." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B41508452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Verstappen, Annita A. (Annita Apollonia). "Cellular mechanisms of ocular hypotensive effects of a₂-adrenergic agonists." Thesis, University of North Texas, 1993. https://digital.library.unt.edu/ark:/67531/metadc798263/.

Full text
Abstract:
Th ocular bilateral hypotensive effect after unilateral topical administration of medetomidine and 4 analogs was demonstrated in a dose-response study (0.5%-2%) in NZW rabbits (bilateral IOP-lowering efficacy: medetomidine>detomidine and MPV-1440>MPV-1441 and MPV-305BIII).
APA, Harvard, Vancouver, ISO, and other styles
4

Zolty, Ronald. "Beta 1 and Alpha 2C adrenergic receptor polymorphisms and response to beta blockers in heart failure patients /." Connect to full text via ProQuest. Limited to UCD Anschutz Medical Campus, 2007.

Find full text
Abstract:
Thesis (Ph.D. in Clinical Science) -- University of Colorado Denver, 2007.<br>Typescript. Includes bibliographical references (leaves 130-142). Free to UCD affiliates. Online version available via ProQuest Digital Dissertations;
APA, Harvard, Vancouver, ISO, and other styles
5

Liu, Jie, and 劉潔. "Intranasal dexmedetomidine for sedation." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41508452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cheung, Chi-wai, and 張志偉. "Role of dexmedetomidine on acute postoperative pain management." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B4684868X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wong, Sze-wan Emily, and 黃詩韻. "Vascular effects of the intravenous anaesthetic dexmedetomidine." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46925612.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tran, Tung Vu. "Ocular Hypotensive Effect of the α2-Adrenergic Agonist, Lofexidine". Thesis, University of North Texas, 1989. https://digital.library.unt.edu/ark:/67531/metadc501156/.

Full text
Abstract:
A selective a2-adrenergic agonist, lofexidine, significantly reduced intraocular pressure (lOP) in intact ocular normotensive NZW rabbits, producing a differential dose-dependent decrease in IOP in'the ipsilateral and contralateral eye. Contralateral IOP reduction was most observable at low doses. Unilateral superior cervical ganglionectomy and extraocular muscle excision studies were undertaken to elucidate the factors influencing differential IOP reduction by lofexidine. Similar significant contralateral decreases in IOP were noted when the agent was applied to either the intact or operated
APA, Harvard, Vancouver, ISO, and other styles
9

Walker, Suellen Monica. "Inhibitory modulation of spinal pain pathways by alpha2-adrenergic agonists: effect of developmental age." Thesis, The University of Sydney, 2005. https://hdl.handle.net/2123/27911.

Full text
Abstract:
Understanding developmental changes in nociceptive processing and pharmacodynamic responses to analgesics is crucial for advances in paediatric pain management. This thesis investigates primary and secondary hyperalgesia induced by C-fibre stimuli and the analgesic efficacy of the alphaz-adrenergic agonist dexmedetomidine, at different postnatal ages in the rat pup. In anaesthetised rat pups, the effect of capsaicin or mustard oil on the hindlimb withdrawal reflex was quantified by electromyography (EMG) responses to hindpaw mechanical stimuli. In postnatal day (P) 10 and P21 pups, di
APA, Harvard, Vancouver, ISO, and other styles
10

Vicentini, Fabio Carvalho. "Efeito da tansulosina e do nifedipino na eliminação de fragmentos após litotripsia extracorpórea por ondas de choque em pacientes com cálculos renais: estudo prospectivo, duplo-cego e randomizado." Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/5/5153/tde-05052011-122956/.

Full text
Abstract:
Introdução: A litotripsia extracorpórea por ondas de choque (LEOC) é o tratamento mais utilizado para cálculos renais de até 20 mm. O uso adjuvante de algumas drogas pode aumentar as taxas de sucesso do procedimento e diminuir a sua morbidade. Objetivos: Avaliar os efeitos da tansulosina e do nifedipino nas taxas de sucesso, nos episódios de dor e na velocidade de eliminação dos fragmentos após o tratamento de cálculos renais de 5 a 20 mm com uma única sessão de LEOC. Casuística e Métodos: Foram estudados prospectivamente 136 indivíduos portadores de cálculos renais entre 5 e 20 mm, submetidos
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Alpha-blockers"

1

Helge, Refsum, and Mjøs Ole D. 1939-, eds. [Alpha]-adrenoceptor blockers in cardiovascular disease. Churchill Livingstone, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

T, Lowenthal David, ed. Benign prostatic hyperplasia: Maximizing treatment with alpha blockers. Advanstar Communications Inc., 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

S, Kirby R., and Bartsch G, eds. The role of alpha-blockers in benign prostatic hyperplasia. PharmaLibri, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

E, Short Charles, ed. Alpha₂-agents in animals: Sedation, analgesia, and anaesthesia. Veterinary Practice Pub. Co., 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kaum, Heinz-Josef. Beeinflussung des Plasma-Katecholamin-Spiegels durch eine antihypertensive Therapie mit adrenergen Rezeptorenblockern: Vergleich des Alpha-Blockers Prazosin mit dem Beta-Blocker Atenolol bei Patienten mit essentieller Hypertonie unter Ruhe- und unter Belastungsbedingungen. [s.n.], 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

The Role of Alpha-Blockers in Benign Prostatic Hyperplasia (Pharmanual (Chicago, Ill.).). Pharma Libri Pub, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Laurent, Ed Boccon-Gibod. Do Alpha-blockers Impact On The Natural History Of Bph? (Supplement Issue: European Urology 2001). Karger, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Schmitt, Gertrud. Wirksamkeit des Alpha- und Beta-Rezeptoren-Blockers Medroxalol in verschiedenen Dosierungen im kontrollierten Arbeitsversuch bei Patienten mit koronarer Herzerkrankung. 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

McGrane, Tracy. Alcohol Withdrawal. Edited by Matthew D. McEvoy and Cory M. Furse. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190226459.003.0093.

Full text
Abstract:
This chapter, “Alcohol Withdrawal,” reviews the prevalence, presentation, pathophysiology, and anesthetic considerations for patients encountered at risk of alcohol withdrawal, as well as current intensive care unit practices caring for patients at risk of alcohol withdrawal to allow for improved perioperative crisis management. It reviews physiologic derangements in both acute and chronic alcoholism, and reviews the current evidence for prevention and treatment of alcohol withdrawal in the intensive care unit, including fixed-dose versus loading-dose versus symptom-based treatment using benzo
APA, Harvard, Vancouver, ISO, and other styles
10

Rai, Samarpit, Zachariah G. Goldsmith, Michael E. Lipkin, and Glenn M. Preminger. Ureteric stones. Edited by John Reynard. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0026.

Full text
Abstract:
Acute renal colic is a common presentation to the emergency department. It is estimated that about 12% of men and 5% of women will have at least one symptomatic stone by the age of 70. Renal colic has an annual incidence 16 cases per 10,000 per year, and a lifetime incidence of 2–5%. In the year 2000, there were over 600,000 emergency room visits for urolithiasis listed as the primary diagnosis in the United States alone. In this chapter, acute pharmacologic management of patients diagnosed with ureteral stones will be outlined. The pharmacology and clinical efficacy for narcotic and non-narco
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Alpha-blockers"

1

Bhandari, Prasan. "Alpha-adrenergic blocking agents (α blockers)." In Pharmacology Mind Maps for Medical Students and Allied Health Professionals. CRC Press, 2019. http://dx.doi.org/10.1201/9780429023859-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Franco, Kevin. "Alpha Blockers and Finasteride for BPH-1996." In Top Articles in Primary Care. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-25620-2_54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Frishman, William H., Angela Cheng-Lai, and Julie Chen. "Alpha-Adrenergic Blockers (Peripherally Acting Antihypertensive Agents)." In Current Cardiovascular Drugs. Current Medicine Group, 2000. http://dx.doi.org/10.1007/978-1-4615-6767-7_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Johnson, Ericka. "Alpha-blockers and a weaker pharmaceutical influence on medical discourse." In Glocal Pharma. Routledge, 2016. http://dx.doi.org/10.4324/9781315585185-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cleophas, Ton J. M. "Alpha-Blocker Induced Hypotension and Fluid Retention Prevented by Nonselective Beta-Blockers." In Beta-Blockers in Hypertension and Angina Pectoris. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0129-5_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shah, Milap, B. M. Zeeshan Hameed, Amelia Pietropaolo, and Bhaskar K. Somani. "Use of Drugs to Reduce the Morbidity of Ureteral Stents." In Urinary Stents. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-04484-7_7.

Full text
Abstract:
AbstractDouble ureteral stents are amongst the commonest procedures performed in urology. However, there are complications such as infection, and encrustation associated with its use, together with uncomfortable lower urinary tract symptoms (LUTS). The latter are known as stent related symptoms (SRS) and are commonly reported in the scientific literature. SRS mentioned in literature are urgency, frequency, dysuria, haematuria, pain in the suprapubic and flank region. These can result in decreased sexual activity, reduced work performance, as well as decreased quality of life (QoL) in more than
APA, Harvard, Vancouver, ISO, and other styles
7

Miller, S. M., and K. L. Cumpston. "Alpha Blockers." In Encyclopedia of Toxicology. Elsevier, 2014. http://dx.doi.org/10.1016/b978-0-12-386454-3.00714-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barrett, Orit, and Talya Wolak. "Peripheral Alpha Blockers." In Hypertension. Elsevier, 2024. http://dx.doi.org/10.1016/b978-0-323-88369-6.00025-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Patil, Shankar, Muzahir Tayebjee, and Sunil K. Nadar. "Other antihypertensive agents." In Hypertension (Oxford Cardiology Library) 3E, 3rd ed., edited by Sunil K. Nadar and Gregory Y. H. Lip. Oxford University PressOxford, 2022. http://dx.doi.org/10.1093/med/9780198870678.003.0018.

Full text
Abstract:
Abstract First-line agents for management of hypertension include beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, calcium channel blockers, and diuretics. However, a sizeable proportion of patients have hard-to-treat hypertension or resistant hypertension, and require the addition of other agents such as alpha adrenergic blockers or centrally acting drugs. These drugs are not recommended for initiation of therapy in newly diagnosed hypertension. However, they are recommended as add-on therapy in difficult-to-treat hypertension. This chapter will review
APA, Harvard, Vancouver, ISO, and other styles
10

Duncan, Richards, and Jeffrey Aronson. "Urinary tract: Alpha-adrenoceptor antagonists (alpha-blockers): BNF 7.4.1 and 2.5.4." In Oxford Handbook of Practical Drug Therapy. Oxford University Press, 2005. http://dx.doi.org/10.1093/med/1.1.med-9780198530077-div1-156.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Alpha-blockers"

1

Vodnizza, SE Ibáñez, MT Nurmohamed, IM Visman, JC van Denderen, WF Lems, and IE der Horst-Bruinsma van. "SAT0421 Fat mass negatively affects the response to tnf alpha blockers in ankylosing spondylitis patients." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.1189.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Murtola, Teemu J., та Teuvo L. J. Tammela. "Abstract A97: Risk of biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers". У Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1940-6207.prev-11-a97.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Moltό, A., A. Etcheto, L. Gossec, et al. "THU0346 Concomitant fibromyalgia in axial spondyloarthritis has a negative impact on tnf alpha blockers treatment effect in real life." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.2509.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Meghnathi, B., A. Etcheto, P. Claudepierre, M. Dougados, and A. Moltό. "SAT0386 Extreme patient reported outcome (PRO) in early spondyloarthritis: a surrogate for fibromyalgia? its impact on TNF-ALPHA blockers treatment effect?" In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3827.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Alijotas-Reig, Jaume, Enrique Esteve-Valverde, Elisa Llurba, and Josep Mª Gris. "FRI0191 TREATMENT OF REFRACTORY POOR APL-RELATED OBSTETRIC OUTCOMES WITH TNF-ALPHA BLOCKERS: MATERNAL-FETAL OUTCOMES IN A SERIES OF 18 CASES." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.1279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pinheiro, Amanda Pereira Sindeaux, Pedro Vitor Ferreira Rodrigues, Raoni de Oliveira da Silva Domingues, and Leonardo José Rodrigues Araújo Melo. "Gastrointestinal dysmotility associated with Parkinson’s disease’s mechanism." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.461.

Full text
Abstract:
Introduction: Parkinson’s Disease (PD) is a condition of the brain that consiste of the death of dopaminergic neurons in the substantia nigra, therefore causing dyskinesias and dystonias. Besides the motor symptoms, the neurogastro motility is affected by the disease, since gastrointestinal dysfunction is a frequent and clinically relevant symptom of PD. Objectives: To link the neural pathways and neurotransmitters that involve the neuroenteric system control and the PD’s pathology. Methods: A systematic literature review was performed based on data extraction through the advanced research eng
APA, Harvard, Vancouver, ISO, and other styles
7

Batul1, Samiya, Wasaf Naeem2, and Dr Humeira Igbal3. "Optimal Nutrition during Pregnancy: Food Intake Versus Supplementation." In 4th International Nutrition and Dietetics Scientific Conference. KENYA NUTRITIONISTS AND DIETICIANS INSTITUTE, 2024. http://dx.doi.org/10.57039/jnd-conf-abt-2024-mfpch-18.

Full text
Abstract:
During the COVID-19 pandemic, dietary habits shifted towards homemade and organic foods due to restrictions on dining out. This case study explores the impact of adequate food intake, focusing on organic sources, versus supplementation on the health of a pregnant woman and her baby. A 37-year-old pregnant woman, in her 11th week, was diagnosed with calcium lithiasis and hydronephropathy, exacerbated by a family history of calcium oxalate stones. After a 20-day treatment regimen with antibiotics, painkillers, and alpha blockers, she was advised against inorganic calcium and vitamin D supplement
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Alpha-blockers"

1

Gao, JianGang, ZeWei Yu, and Lee Wan. Efficacy and Safety of alpha adrenergic blockers in the Medical Expulsion Therapy for Ureteral Calculi. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.12.0040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Alpha-blockers' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography